ZUMA24
Loading viewer...
report
Format: PDF report
ZUMA-24 is a Phase 2 study evaluating the safety and efficacy of Axicabtagene Ciloleucel for relapsed or refractory large B-cell lymphoma in outpatient settings.
Loading viewer...
report
Format: PDF report
ZUMA-24 is a Phase 2 study evaluating the safety and efficacy of Axicabtagene Ciloleucel for relapsed or refractory large B-cell lymphoma in outpatient settings.
brochure
report
Grab
report
Embotelladora Andina
report
Drybar
report
Energizer Holdings
